Femme Noir

Shared Care Agreement Hydroxychloroquine: What It Is and Why It Matters

Hydroxychloroquine, a medication primarily used to treat malaria and autoimmune disorders such as lupus and rheumatoid arthritis, has been the subject of significant controversy in recent years. This is due, in part, to its potential use as a treatment for COVID-19, which has led to shortages and increased scrutiny of its effectiveness and safety.

Shared care agreements, sometimes referred to as joint care agreements, are a way to manage the use of high-risk medications like hydroxychloroquine. These agreements help ensure that patients receive the necessary care and monitoring to minimize potential risks and maximize benefits.

What Is a Shared Care Agreement?

A shared care agreement is a formal agreement between the patient, their healthcare provider, and a specialist or other healthcare professional. It outlines the responsibilities of all parties involved in managing the patient`s care and provides a framework for communication, monitoring, and review.

In the case of hydroxychloroquine, a shared care agreement might include guidelines for monitoring the patient`s blood pressure, kidney and liver function, and eye health, as this medication can cause serious side effects if not properly monitored.

Why Is a Shared Care Agreement Important for Hydroxychloroquine?

Hydroxychloroquine has been the subject of numerous studies, heated discussions, and political controversies. While some early studies suggested that the medication might be effective in treating COVID-19, subsequent research has failed to support these claims. Additionally, hydroxychloroquine has potentially serious side effects, including damage to the eyes, liver, and kidneys.

For patients who require hydroxychloroquine, a shared care agreement can help ensure that they receive the necessary monitoring and care to minimize these risks and maximize the medication`s potential benefits. The agreement also helps to ensure that the prescribing physician is aware of any other medications the patient is taking, as hydroxychloroquine can interact with various other drugs.

In summary, shared care agreements are an essential tool in managing the use of high-risk medications like hydroxychloroquine. They help ensure that patients receive appropriate monitoring and care while minimizing the risk of potentially serious side effects. As the health care industry continues to evolve, shared care agreements will likely become even more important in managing complex medication regimens.